165 related articles for article (PubMed ID: 37024472)
1. Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer.
Xia K; Li S; Yang Y; Shi X; Zhao B; Lv L; Xin Z; Kang J; Ren P; Wu H
Cell Death Dis; 2023 Apr; 14(4):250. PubMed ID: 37024472
[TBL] [Abstract][Full Text] [Related]
2. The circadian gene CRY2 is associated with breast cancer aggressiveness possibly via epigenomic modifications.
Mao Y; Fu A; Hoffman AE; Jacobs DI; Jin M; Chen K; Zhu Y
Tumour Biol; 2015 May; 36(5):3533-9. PubMed ID: 25740058
[TBL] [Abstract][Full Text] [Related]
3. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel cryptochrome differentiating domain required for feedback repression in circadian clock function.
Khan SK; Xu H; Ukai-Tadenuma M; Burton B; Wang Y; Ueda HR; Liu AC
J Biol Chem; 2012 Jul; 287(31):25917-26. PubMed ID: 22692217
[TBL] [Abstract][Full Text] [Related]
5. Critical cholangiocarcinogenesis control by cryptochrome clock genes.
Mteyrek A; Filipski E; Guettier C; Oklejewicz M; van der Horst GT; Okyar A; Lévi F
Int J Cancer; 2017 Jun; 140(11):2473-2483. PubMed ID: 28224616
[TBL] [Abstract][Full Text] [Related]
6. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling.
Hoffman AE; Zheng T; Yi CH; Stevens RG; Ba Y; Zhang Y; Leaderer D; Holford T; Hansen J; Zhu Y
Cancer Prev Res (Phila); 2010 Apr; 3(4):539-48. PubMed ID: 20233903
[TBL] [Abstract][Full Text] [Related]
7. Cryptochrome 2 (CRY2) Suppresses Proliferation and Migration and Regulates Clock Gene Network in Osteosarcoma Cells.
Yu Y; Li Y; Zhou L; Yang G; Wang M; Hong Y
Med Sci Monit; 2018 Jun; 24():3856-3862. PubMed ID: 29879092
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic effects of the circadian gene Cryptochrome 2 on cancer-related pathways.
Hoffman AE; Zheng T; Ba Y; Stevens RG; Yi CH; Leaderer D; Zhu Y
BMC Cancer; 2010 Mar; 10():110. PubMed ID: 20334671
[TBL] [Abstract][Full Text] [Related]
9. Expression of circadian core clock genes in fibroblasts of human gingiva and periodontal ligament is modulated by L-Mimosine and hypoxia in monolayer and spheroid cultures.
Janjić K; Kurzmann C; Moritz A; Agis H
Arch Oral Biol; 2017 Jul; 79():95-99. PubMed ID: 28350992
[TBL] [Abstract][Full Text] [Related]
10. The Potorous CPD photolyase rescues a cryptochrome-deficient mammalian circadian clock.
Chaves I; Nijman RM; Biernat MA; Bajek MI; Brand K; da Silva AC; Saito S; Yagita K; Eker AP; van der Horst GT
PLoS One; 2011; 6(8):e23447. PubMed ID: 21858120
[TBL] [Abstract][Full Text] [Related]
11. Circadian disruption does not alter tumorigenesis in a mouse model of lymphoma.
Mello RM; Pariollaud M; Lamia KA
F1000Res; 2023; 12():49. PubMed ID: 37811199
[No Abstract] [Full Text] [Related]
12. Suppression of circadian clock protein cryptochrome 2 promotes osteoarthritis.
Bekki H; Duffy T; Okubo N; Olmer M; Alvarez-Garcia O; Lamia K; Kay S; Lotz M
Osteoarthritis Cartilage; 2020 Jul; 28(7):966-976. PubMed ID: 32339698
[TBL] [Abstract][Full Text] [Related]
13. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock.
Etchegaray JP; Lee C; Wade PA; Reppert SM
Nature; 2003 Jan; 421(6919):177-82. PubMed ID: 12483227
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of cryptochrome genes in human colorectal cancer.
Mazzoccoli G; Colangelo T; Panza A; Rubino R; De Cata A; Tiberio C; Valvano MR; Pazienza V; Merla G; Augello B; Trombetta D; Storlazzi CT; Macchia G; Gentile A; Tavano F; Vinciguerra M; Bisceglia G; Rosato V; Colantuoni V; Sabatino L; Piepoli A
Mol Cancer; 2016 Jan; 15():6. PubMed ID: 26768731
[TBL] [Abstract][Full Text] [Related]
15. Molecular assembly of the period-cryptochrome circadian transcriptional repressor complex.
Nangle SN; Rosensweig C; Koike N; Tei H; Takahashi JS; Green CB; Zheng N
Elife; 2014 Aug; 3():e03674. PubMed ID: 25127877
[TBL] [Abstract][Full Text] [Related]
16. CRY2 and FBXL3 Cooperatively Degrade c-MYC.
Huber AL; Papp SJ; Chan AB; Henriksson E; Jordan SD; Kriebs A; Nguyen M; Wallace M; Li Z; Metallo CM; Lamia KA
Mol Cell; 2016 Nov; 64(4):774-789. PubMed ID: 27840026
[TBL] [Abstract][Full Text] [Related]
17. Arabidopsis cryptochrome 2 forms photobodies with TCP22 under blue light and regulates the circadian clock.
Mo W; Zhang J; Zhang L; Yang Z; Yang L; Yao N; Xiao Y; Li T; Li Y; Zhang G; Bian M; Du X; Zuo Z
Nat Commun; 2022 May; 13(1):2631. PubMed ID: 35551190
[TBL] [Abstract][Full Text] [Related]
18. DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization.
Papp SJ; Huber AL; Jordan SD; Kriebs A; Nguyen M; Moresco JJ; Yates JR; Lamia KA
Elife; 2015 Mar; 4():. PubMed ID: 25756610
[TBL] [Abstract][Full Text] [Related]
19. In vivo role of phosphorylation of cryptochrome 2 in the mouse circadian clock.
Hirano A; Kurabayashi N; Nakagawa T; Shioi G; Todo T; Hirota T; Fukada Y
Mol Cell Biol; 2014 Dec; 34(24):4464-73. PubMed ID: 25288642
[TBL] [Abstract][Full Text] [Related]
20. Quantification of interactions among circadian clock proteins via surface plasmon resonance.
Kepsutlu B; Kizilel R; Kizilel S
J Mol Recognit; 2014 Jul; 27(7):458-69. PubMed ID: 24895278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
